Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment

ABSTRACT Breast cancer is among the most common cancers in U.S. women. Epidermal growth factor receptor inhibitors (EGFRIs) target pathways driving tumor growth but frequently cause dermatologic toxicities that impact quality of life and treatment adherence. This review summarizes the clinical featu...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Tvisha Devireddy, Clara Lim, Jhillika Patel, Isabella J. Tan, Bernard A. Cohen
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-12-01
Serija:	Clinical and Translational Science
Teme:	breast cancer chemotherapy‐induced skin toxicity cutaneous adverse effects dermatologic management epidermal growth factor receptor inhibitors quality of life
Online dostop:	https://doi.org/10.1111/cts.70432
Oznake:	Označite Brez oznak, prvi označite!